Molina Healthcare/$MOH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Molina Healthcare

Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.

Ticker

$MOH

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

18,000

ISIN

US60855R1005

MOH Metrics

BasicAdvanced
$16B
14.28
$20.69
0.70
-

What the Analysts think about MOH

Analyst ratings (Buy, Hold, Sell) for Molina Healthcare stock.

Bulls say / Bears say

Molina Healthcare's strategic acquisitions, such as the purchase of ConnectiCare, are expected to positively impact earnings per share by 2025, enhancing the company's market position. (Investing.com)
The company reported a significant 18% year-over-year increase in premium revenue for Q3 2024, indicating strong growth in its Medicaid insurance plans. (Reuters)
Analysts project potential upside in Molina's 2025 EPS growth, with estimates ranging from $26.75 to $28.46, reflecting confidence in the company's future profitability. (Investing.com)
Molina Healthcare's fourth quarter of 2024 presented a 13% earnings per share miss, primarily due to a 170 basis point miss on the Medical Loss Ratio across its Medicaid, Medicare, and Marketplace segments. (Investing.com)
The company's initial EPS guidance for 2025 of at least $24.50 falls below consensus estimates, indicating potential challenges in meeting analyst expectations. (Investing.com)
Molina Healthcare's stock has declined by 32.22% over the past year, trading near its 52-week low, which may reflect investor concerns about the company's performance. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

MOH Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MOH Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MOH

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs